Fraxinus, Qín Pí, 秦皮, Cortex Fraxini
Disclaimer For educational purposes only. Do not use as medical advice
Space Space
Space USA: Fraxinus rhynchophylla Hance USDA Zones: Native: Habitats: Herbal medicine may interact negatively with pharma drugs and other herbs. Examples below: Herbs: Pharma Drugs:Contains coumarin which may reaction with blood thinner medication
Health Benefits
For: Dysenteric disorders • Bi pain • Gout • Diarrhea • Bronchitis • Red eyes • Foul leukorrhea
Attributes: Anti-inflammatory • Analgesic • Diurectic • Expectorant • Sedative • Antitussive • Anticonvulsant
Products (online examples)
Space
Space
Research (sample)
Articles:
Constituents:
Coumarin • Tannin
Photos (Click to enlarge)
Fun Facts
Other Names: La Shu Pi • Ash bark
Plant Family:
Pharmacopeias: Shen Nong Ben Cao Jing
Species
Growth
TBD
TBD
Fraxinus rhynchophylla Hance is not in the USDA Plant Database. Drill down via USDA Interactive Map:
Category: Clear Heat Dry Dampness
English: Fraxinus Pinyin: Qin Pi Pharmaceutical: Cortex Fraxini
Organs: Gallbladder • Liver • Stomach • Large Intestine Temperature: Cold
Taste: Bitter • Astringent Toxicity:
Patterns: Liver fire • Dampness
Actions: Dry dampness • Clear heat • Sedate liver fire • Benefit eyes • Calm wheezing • Stop cough • Stop diarrhea
Indications: Dysenteric disorders • Diarrhea • Wind damp Bi pain • Wheezing • Cough • Red eyes • Damp heat leukorrhea
Contraindications: Spleen and stomach deficiency cold
Typical Dosage: 6g to 12g Guidelines
Parts Used: Bark
Other:
Combine With
Purpose
Formulas with Qin Pi
Bai Tou Weng Tang
Alert
Be cautions with all medicine.
Potential Drug Interactions
Information in this post came from many sources, including class notes, practitioners, websites, webinars, books, magazines, and editor's personal experience. While the original source often came from historical Chinese texts, variations may result from the numerous English translations. Always consult a doctor prior to using these drugs. The information here is strictly for educational purposes.
0 Comments